Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens
We investigated whether telomerase activity and viral gene transcription were associated with protection against the RB-1B strain of Marek's disease virus (MDV) in chickens vaccinated with Rispens CVI988 or the herpes virus of turkey (HVT). Telomerase activity in peripheral blood leukocytes (PBLs) seemed to be an appropriate marker of lymphoma and levels of viral transcription were correlated with the virulence of MDV strains. Vaccinated protected birds had lower levels of telomerase activity and RB-1B viral gene transcription than unvaccinated chickens infected with RB-1B. The decrease in RB-1B viral transcription was more marked in chickens vaccinated with CVI988 than in those vaccinated with HVT. Indeed, RB-1B viral transcription was not detectable after 14 days post-challenge. In conclusion, telomerase activity and gene transcription in challenge MDV strains are potential new reliable criteria of protection in vaccinated chickens.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Vaccine - 26(2008), 38 vom: 08. Sept., Seite 4904-12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Debba-Pavard, Manel [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers, Tumor |
---|
Anmerkungen: |
Date Completed 23.10.2008 Date Revised 19.11.2015 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.vaccine.2008.07.038 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM181380196 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM181380196 | ||
003 | DE-627 | ||
005 | 20231223161141.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2008.07.038 |2 doi | |
028 | 5 | 2 | |a pubmed24n0605.xml |
035 | |a (DE-627)NLM181380196 | ||
035 | |a (NLM)18680776 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Debba-Pavard, Manel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.10.2008 | ||
500 | |a Date Revised 19.11.2015 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We investigated whether telomerase activity and viral gene transcription were associated with protection against the RB-1B strain of Marek's disease virus (MDV) in chickens vaccinated with Rispens CVI988 or the herpes virus of turkey (HVT). Telomerase activity in peripheral blood leukocytes (PBLs) seemed to be an appropriate marker of lymphoma and levels of viral transcription were correlated with the virulence of MDV strains. Vaccinated protected birds had lower levels of telomerase activity and RB-1B viral gene transcription than unvaccinated chickens infected with RB-1B. The decrease in RB-1B viral transcription was more marked in chickens vaccinated with CVI988 than in those vaccinated with HVT. Indeed, RB-1B viral transcription was not detectable after 14 days post-challenge. In conclusion, telomerase activity and gene transcription in challenge MDV strains are potential new reliable criteria of protection in vaccinated chickens | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
650 | 7 | |a Marek Disease Vaccines |2 NLM | |
650 | 7 | |a Telomerase |2 NLM | |
650 | 7 | |a EC 2.7.7.49 |2 NLM | |
700 | 1 | |a Ait-Lounis, Aouatef |e verfasserin |4 aut | |
700 | 1 | |a Soubieux, Denis |e verfasserin |4 aut | |
700 | 1 | |a Rasschaert, Denis |e verfasserin |4 aut | |
700 | 1 | |a Dambrine, Ginette |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g 26(2008), 38 vom: 08. Sept., Seite 4904-12 |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2008 |g number:38 |g day:08 |g month:09 |g pages:4904-12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2008.07.038 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2008 |e 38 |b 08 |c 09 |h 4904-12 |